Cite
HARVARD Citation
Kawamoto, K. et al. (2018). Frequent expression of CD30 in extranodal NK/T‐cell lymphoma: Potential therapeutic target for anti‐CD30 antibody‐based therapy. Hematological oncology. 36 (1), pp. 166-173. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kawamoto, K. et al. (2018). Frequent expression of CD30 in extranodal NK/T‐cell lymphoma: Potential therapeutic target for anti‐CD30 antibody‐based therapy. Hematological oncology. 36 (1), pp. 166-173. [Online].